The Empaveli Injector is a wearable device designed for adults suffering from paroxysmal nocturnal hemoglobinuria. It allows for hands-free drug delivery of up to 25 mL and can be used for at-home or in-clinic use. (Image: Enable Inections)

In this episode, we explore advancements in wearable injector technology, examining how these devices are transforming the administration of medications, improving patient adherence, and enhancing the overall effectiveness of treatment plans. Our guest is Matt Huddleston, chief technology officer and executive vice president of Enable Injections, who talks about the enFuse infusion platform.

Subscribe  to the Medical Design Briefs podcast on Apple Podcasts  or Spotify .